日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Suppression of STK11 induces expansion of polymorphonuclear myeloid-derived suppressive cells and activation of immune signaling in breast cancer

STK11的抑制可诱导多形核髓系来源抑制细胞的扩增和乳腺癌中免疫信号的激活。

Wei, Tzu-Hui; Hsieh, Chi-Che; Loh, Zhu-Jun; Chung, Wei-Pang; Lee, Kuo-Ting; Chen, Yi-Ling; Hsu, Hui-Ping; Shen, Che-Hung

RNF43 Inactivation Enhances the B-RAF/MEK Signaling and Creates a Combinatory Therapeutic Target in Cancer Cells.

RNF43 失活增强了 B-RAF/MEK 信号传导,并为癌细胞创造了一个联合治疗靶点

Hsu Shih-Han, Tsai Ya-Li, Wang Yeng-Tseng, Shen Che-Hung, Hung Yu-Hsuan, Chen Li-Tzong, Hung Wen-Chun

DKK1 as a chemoresistant protein modulates oxaliplatin responses in colorectal cancer

DKK1作为一种化疗耐药蛋白,可调节结直肠癌对奥沙利铂的反应

Hsieh, Chi-Che; Li, Ting-Wei; Li, Chun-Chun; Chen, Shang-Hung; Wei, You-Lin; Chiang, Nai-Jung; Shen, Che-Hung

TRPM1 promotes tumor progression in acral melanoma by activating the Ca(2+)/CaMKIIδ/AKT pathway

TRPM1通过激活Ca(2+)/CaMKIIδ/AKT通路促进肢端黑色素瘤的肿瘤进展。

Hsieh, Chi-Che; Su, Yue-Chiu; Jiang, Kuan-Ying; Ito, Takamichi; Li, Ting-Wei; Kaku-Ito, Yumiko; Cheng, Shih-Tsung; Chen, Li-Tzong; Hwang, Daw-Yang; Shen, Che-Hung

CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer

CHK2激活促进结直肠癌对奥沙利铂产生耐药性

Hsieh, Chi-Che; Hsu, Sen-Huei; Lin, Chih-Yu; Liaw, Hung-Jiun; Li, Ting-Wei; Jiang, Kuan-Ying; Chiang, Nai-Jung; Chen, Shang-Hung; Lin, Bo-Wen; Chen, Po-Chuan; Chan, Ren-Hao; Lin, Peng-Chan; Yeh, Yu-Min; Shen, Che-Hung

Phthalate Exposure Pattern in Breast Milk within a Six-Month Postpartum Time in Southern Taiwan

台湾南部地区产后六个月内母乳中邻苯二甲酸酯的暴露模式

Shen-Che Hung, Ting-I Lin, Jau-Ling Suen, Hsien-Kuan Liu, Pei-Ling Wu, Chien-Yi Wu, Yu-Chen S H Yang, San-Nan Yang, Yung-Ning Yang

Phosphorylation of BRAF by AMPK impairs BRAF-KSR1 association and cell proliferation

AMPK对BRAF的磷酸化会损害BRAF-KSR1的结合和细胞增殖。

Shen, Che-Hung; Yuan, Ping; Perez-Lorenzo, Rolando; Zhang, Yaqing; Lee, Sze Xian; Ou, Yang; Asara, John M; Cantley, Lewis C; Zheng, Bin

Phenformin enhances the therapeutic benefit of BRAF(V600E) inhibition in melanoma.

苯乙双胍可增强 BRAF(V600E) 抑制剂在黑色素瘤治疗中的疗效

Yuan Ping, Ito Koichi, Perez-Lorenzo Rolando, Del Guzzo Christina, Lee Jung Hyun, Shen Che-Hung, Bosenberg Marcus W, McMahon Martin, Cantley Lewis C, Zheng Bin

Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin

Brk激活rac1,并通过磷酸化paxillin促进细胞迁移和侵袭。

Chen, Hsin-Yi; Shen, Che-Hung; Tsai, Yuh-Tyng; Lin, Feng-Chi; Huang, Yuan-Ping; Chen, Ruey-Hwa